Research programme: antifungals - Celltech Group
Alternative Names: Antifungals research programme - Celltech Group; Peptide mannosyl transferase I inhibitors research programme - Celltech Group; PMT-1 inhibitors research programme - Celltech Group; Research programme: peptide mannosyl transferase I inhibitors - Celltech Group; Research programme: PMT-1 inhibitors - Celltech GroupLatest Information Update: 12 Dec 2003
At a glance
- Originator Celltech Group
- Class
- Mechanism of Action Cell wall inhibitors; Peptide mannosyl transferase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 12 Dec 2003 Discontinued - Preclinical for Mycoses in United Kingdom (unspecified route)
- 08 Dec 2003 The integration of Oxford GlycoSciences into Celltech Group has been completed
- 31 Jul 2003 Oxford GlycoSciences has been acquired by Celltech Group